These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. New peptidic cysteine protease inhibitors derived from the electrophilic alpha-amino acid aziridine-2,3-dicarboxylic acid. Schirmeister T J Med Chem; 1999 Feb; 42(4):560-72. PubMed ID: 10052963 [TBL] [Abstract][Full Text] [Related]
23. Cathepsin B-like activity predominates over cathepsin L-like activity in adult Schistosoma mansoni and S. japonicum. Caffrey CR; Ruppel A Parasitol Res; 1997; 83(6):632-5. PubMed ID: 9211519 [TBL] [Abstract][Full Text] [Related]
24. Inhibition of carcinoma cell invasion and liver metastases formation by the cysteine proteinase inhibitor E-64. Navab R; Mort JS; Brodt P Clin Exp Metastasis; 1997 Mar; 15(2):121-9. PubMed ID: 9062388 [TBL] [Abstract][Full Text] [Related]
25. Immunological studies on cathepsins B and H from rat liver. Kominami E; Katunuma N J Biochem; 1982 Jan; 91(1):67-71. PubMed ID: 6175627 [TBL] [Abstract][Full Text] [Related]
26. A selective cysteine protease inhibitor is non-toxic and cerebroprotective in rats undergoing transient middle cerebral artery ischemia. Seyfried DM; Veyna R; Han Y; Li K; Tang N; Betts RL; Weinsheimer S; Chopp M; Anagli J Brain Res; 2001 May; 901(1-2):94-101. PubMed ID: 11368955 [TBL] [Abstract][Full Text] [Related]
27. Design, Synthesis, and Structure-Activity Relationship Study of Epoxysuccinyl-Peptide Derivatives as Cathepsin B Inhibitors. Zhang X; Yang X; Wang H; Li S; Guo K; Jiang D; Xiao J; Liang D Biol Pharm Bull; 2017 Aug; 40(8):1240-1246. PubMed ID: 28502922 [TBL] [Abstract][Full Text] [Related]
28. Inhibitions by E-64 derivatives of rat liver cathepsin B and cathepsin L in vitro and in vivo. Hashida S; Towatari T; Kominami E; Katunuma N J Biochem; 1980 Dec; 88(6):1805-11. PubMed ID: 7462205 [TBL] [Abstract][Full Text] [Related]
29. Effects of cathepsin B, H, and D in pectoral muscle of dystrophic chickens (line 413) of in vivo administration of E-64-c (N-[N-(L-3-transcarboxyoxirane-2-carbonyl)-L-leucyl]-3-methyl-butylamine). Noda T; Isogai K; Katunuma N; Tarumoto Y; Ohzeki M J Biochem; 1981 Sep; 90(3):893-6. PubMed ID: 7309707 [TBL] [Abstract][Full Text] [Related]
30. Characterization of CAA0225, a novel inhibitor specific for cathepsin L, as a probe for autophagic proteolysis. Takahashi K; Ueno T; Tanida I; Minematsu-Ikeguchi N; Murata M; Kominami E Biol Pharm Bull; 2009 Mar; 32(3):475-9. PubMed ID: 19252298 [TBL] [Abstract][Full Text] [Related]
31. The role of cysteine proteases in hypoxia-induced rat renal proximal tubular injury. Edelstein CL; Wieder ED; Yaqoob MM; Gengaro PE; Burke TJ; Nemenoff RA; Schrier RW Proc Natl Acad Sci U S A; 1995 Aug; 92(17):7662-6. PubMed ID: 7644473 [TBL] [Abstract][Full Text] [Related]
32. Structure based development of novel specific inhibitors for cathepsin L and cathepsin S in vitro and in vivo. Katunuma N; Murata E; Kakegawa H; Matsui A; Tsuzuki H; Tsuge H; Turk D; Turk V; Fukushima M; Tada Y; Asao T FEBS Lett; 1999 Sep; 458(1):6-10. PubMed ID: 10518923 [TBL] [Abstract][Full Text] [Related]
33. Involvement of cathepsin B- and L-like proteinases in silk gland histolysis during metamorphosis of Bombyx mori. Shiba H; Uchida D; Kobayashi H; Natori M Arch Biochem Biophys; 2001 Jun; 390(1):28-34. PubMed ID: 11368511 [TBL] [Abstract][Full Text] [Related]
34. Distinct properties of prohormone thiol protease (PTP) compared to cathepsins B, L, and H: evidence for PTP as a novel cysteine protease. Azaryan AV; Hook VY Arch Biochem Biophys; 1994 Oct; 314(1):171-7. PubMed ID: 7944391 [TBL] [Abstract][Full Text] [Related]
35. Synthesis and biological activity of a series of potent fluoromethyl ketone inhibitors of recombinant human calpain I. Chatterjee S; Ator MA; Bozyczko-Coyne D; Josef K; Wells G; Tripathy R; Iqbal M; Bihovsky R; Senadhi SE; Mallya S; O'Kane TM; McKenna BA; Siman R; Mallamo JP J Med Chem; 1997 Nov; 40(23):3820-8. PubMed ID: 9371247 [TBL] [Abstract][Full Text] [Related]
36. Synthesis of peptide aldehyde derivatives as selective inhibitors of human cathepsin L and their inhibitory effect on bone resorption. Yasuma T; Oi S; Choh N; Nomura T; Furuyama N; Nishimura A; Fujisawa Y; Sohda T J Med Chem; 1998 Oct; 41(22):4301-8. PubMed ID: 9784105 [TBL] [Abstract][Full Text] [Related]
37. Assay procedures for cathepsin B, H and L activities in rat tissue homogenates. Higashi T; Hashimoto M; Watanabe M; Yamauchi Y; Fujiwara M; Nakatsukasa H; Kobayashi M; Watanabe A; Nagashima H Acta Med Okayama; 1986 Feb; 40(1):27-32. PubMed ID: 3962728 [TBL] [Abstract][Full Text] [Related]
38. Active center differences between cathepsins L and B: the S1 binding region. Kirschke H; Wikstrom P; Shaw E FEBS Lett; 1988 Feb; 228(1):128-30. PubMed ID: 3342870 [TBL] [Abstract][Full Text] [Related]
39. Selective cleavage of peptide bonds by cathepsins L and B from rat liver. Towatari T; Katunuma N J Biochem; 1983 Apr; 93(4):1119-28. PubMed ID: 6345516 [TBL] [Abstract][Full Text] [Related]
40. Photometric or fluorometric assay of cathepsin B, L and H and papain using substrates with an aminotrifluoromethylcoumarin leaving group. Tchoupe JR; Moreau T; Gauthier F; Bieth JG Biochim Biophys Acta; 1991 Jan; 1076(1):149-51. PubMed ID: 1986788 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]